(Page 1) To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma (Burlington, Mass.) has launched a new,
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand iltempo.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iltempo.it Daily Mail and Mail on Sunday newspapers.
Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
News provided by
Share this article
NASHVILLE, Tenn., May 11, 2021 /PRNewswire/
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial results. Net revenues from continuing operations during the quarter were $10.5 million, a 26.5% increase over the prior year period. The company also recorded an additional $500,000 in revenue during the first quarter associated with divested product rights for two brands it is no longer distributing.
The Company s financial position included $93 million in total assets - with $25 million in cash, $46 million of total liabilities, and $47 million of shareholders equity at the end of the quarter.